Importantly, efpeglenatides immunogenicity remained relatively low, with few patients developing clinically significant anti-drug antibodies, allowing its safety profile to be viewed as manageable within class expectations
It has not only been shown to help wounds close faster with less chance of infection, but it also seems to be involved in healing ulcers and regenerating lung tissue [1, 2]
Approval and Therapeutic Guidelines Approval The next step after these development studies was the approval of DPP-4 inhibitors by regulatory bodies
Notably, Langley and colleagues reported that despite elevated plasma concentrations of individual antioxidants like ascorbic acid, uric acid, and sulfhydryl groups compared to healthy controls, the CF patients exhibited a significantly reduced TRAP ( Expanding on these observations, serum total antioxidant capacity using ABTS and FRAP assays in a cohort of CF patients was studied ( 7 Antioxidant enzyme activity and levels The assessment of antioxidant enzyme activity in CF is crucial for understanding the redox imbalances that contribute to disease pathogenesis